From monoclonal to polyfunctional immunotherapy: Reprogramming CAR-T-cell therapy with oncolytic viruses in B-cell malignancies.

Achim E, Ungerechts G, Tomuleasa C, Friedel S, Hudecek M, Cristea C, Tertis M, Einsele H.

Open source

DOI
10.1002/hem3.70418
Published
2026-07-07
Container
Hemasphere
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/hem3.70418,
  title = {From monoclonal to polyfunctional immunotherapy: Reprogramming CAR-T-cell therapy with oncolytic viruses in B-cell malignancies.},
  author = {Achim E and  Ungerechts G and  Tomuleasa C and  Friedel S and  Hudecek M and  Cristea C and  Tertis M and  Einsele H.},
  year = {2026},
  journal = {Hemasphere},
  doi = {10.1002/hem3.70418},
  url = {https://doi.org/10.1002/hem3.70418}
}

RIS

TY  - JOUR
TI  - From monoclonal to polyfunctional immunotherapy: Reprogramming CAR-T-cell therapy with oncolytic viruses in B-cell malignancies.
AU  - Achim E
AU  -  Ungerechts G
AU  -  Tomuleasa C
AU  -  Friedel S
AU  -  Hudecek M
AU  -  Cristea C
AU  -  Tertis M
AU  -  Einsele H.
PY  - 2026
JO  - Hemasphere
DO  - 10.1002/hem3.70418
UR  - https://doi.org/10.1002/hem3.70418
ER  - 

APA

E, A., G, U., C, T., S, F., M, H., C, C., M, T., & H., E. (2026). From monoclonal to polyfunctional immunotherapy: Reprogramming CAR-T-cell therapy with oncolytic viruses in B-cell malignancies.. Hemasphere. https://doi.org/10.1002/hem3.70418

Source records